Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Malaysian (KLSE) Pharma Industry Analysis

UpdatedFeb 03, 2026
DataAggregated Company Financials
Companies5
  • 7D-0.9%
  • 3M4.1%
  • 1Y4.6%
  • YTD5.0%

The Pharma industry is up 1.5% in the last week, with Duopharma Biotech Berhad up 3.8%. This means that the industry has gained 3.9% over the past year. Earnings are forecast to grow by 9.9% annually.

Industry Valuation and Performance

Has the Malaysian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 03 Feb 2026RM 2.4bRM 1.9bRM 166.4m14.1x14.7x1.3x
Thu, 01 Jan 2026RM 4.2bRM 2.8bRM 231.9m14.4x18.3x1.5x
Sat, 29 Nov 2025RM 4.2bRM 2.8bRM 231.0m14.5x18.1x1.5x
Mon, 27 Oct 2025RM 4.1bRM 2.8bRM 223.3m15.2x18.5x1.5x
Wed, 24 Sep 2025RM 4.2bRM 2.8bRM 223.3m15.9x18.7x1.5x
Fri, 22 Aug 2025RM 4.2bRM 2.8bRM 223.8m15.8x18.9x1.5x
Sun, 20 Jul 2025RM 4.2bRM 2.8bRM 230.3m16x18.2x1.5x
Tue, 17 Jun 2025RM 4.0bRM 2.8bRM 230.3m15.7x17.5x1.4x
Thu, 15 May 2025RM 3.9bRM 2.8bRM 221.1m17.6x17.8x1.4x
Sat, 12 Apr 2025RM 3.6bRM 2.8bRM 221.0m16.2x16.4x1.3x
Mon, 10 Mar 2025RM 3.8bRM 2.8bRM 221.0m16.6x17.4x1.4x
Wed, 05 Feb 2025RM 4.1bRM 2.7bRM 223.9m17x18.1x1.5x
Fri, 03 Jan 2025RM 4.2bRM 2.7bRM 223.9m16.8x18.6x1.5x
Sun, 01 Dec 2024RM 4.2bRM 2.7bRM 223.9m16.4x18.6x1.5x
Tue, 29 Oct 2024RM 4.4bRM 2.7bRM 230.0m14.2x19x1.6x
Thu, 26 Sep 2024RM 4.5bRM 2.7bRM 230.0m14.7x19.5x1.7x
Sat, 24 Aug 2024RM 4.4bRM 2.7bRM 230.0m15.1x18.9x1.6x
Mon, 22 Jul 2024RM 4.5bRM 2.6bRM 541.3m13x8.2x1.7x
Wed, 19 Jun 2024RM 4.5bRM 2.6bRM 541.3m13.4x8.4x1.7x
Fri, 17 May 2024RM 4.5bRM 2.6bRM 556.4m12.2x8.2x1.7x
Sun, 14 Apr 2024RM 4.6bRM 2.6bRM 559.3m12.3x8.2x1.7x
Tue, 12 Mar 2024RM 4.5bRM 2.6bRM 559.3m12.5x8x1.7x
Thu, 08 Feb 2024RM 4.5bRM 2.6bRM 584.9m12.2x7.8x1.8x
Sat, 06 Jan 2024RM 4.3bRM 2.6bRM 584.9m12.4x7.4x1.7x
Mon, 04 Dec 2023RM 4.2bRM 2.6bRM 584.9m12.1x7.1x1.6x
Wed, 01 Nov 2023RM 4.2bRM 2.6bRM 604.4m12.1x7x1.6x
Fri, 29 Sep 2023RM 4.3bRM 2.6bRM 604.4m12.6x7.1x1.7x
Sun, 27 Aug 2023RM 4.3bRM 2.6bRM 604.6m12.5x7.2x1.7x
Tue, 25 Jul 2023RM 4.4bRM 2.6bRM 304.7m14.2x14.3x1.7x
Thu, 22 Jun 2023RM 4.4bRM 2.6bRM 304.7m14.2x14.3x1.7x
Sat, 20 May 2023RM 4.8bRM 2.5bRM 289.5m13.6x16.5x1.9x
Mon, 17 Apr 2023RM 4.8bRM 2.5bRM 289.8m13.4x16.4x1.9x
Wed, 15 Mar 2023RM 4.6bRM 2.5bRM 289.8m13.1x15.9x1.8x
Fri, 10 Feb 2023RM 4.5bRM 2.4bRM 270.7m13.1x16.5x1.8x
Price to Earnings Ratio

16.5x


Total Market Cap: RM 4.5bTotal Earnings: RM 270.7mTotal Revenue: RM 2.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Malaysian Pharma Industry Price to Earnings3Y Average 14.2x202420252026
Current Industry PE
  • Investors are relatively neutral on the Malaysian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 14.2x.
  • The 3-year average PS ratio of 1.6x is higher than the industry's current PS ratio of 1.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 15% per year over the last three years,
  • Revenues have also declined 8.8% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Trends

Which industries have driven the changes within the Malaysian Healthcare industry?

MY Market-1.32%
Healthcare2.09%
Pharma-0.91%
Pharma-0.91%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
DPHARMA Duopharma Biotech BerhadRM 1.401.4%
+RM 19.2m		14.8%PE16.1x
RHONEMA Rhone Ma Holdings BerhadRM 0.690%
RM 8.3k		2.2%PE11.3x

Latest News

RHONEMA
RM 0.69
Rhone Ma Holdings Berhad
7D
0%
1Y
2.2%
PLABS
RM 0.27
PeterLabs Holdings Berhad
7D
-1.9%
1Y
35.9%

Some Confidence Is Lacking In PeterLabs Holdings Berhad's (KLSE:PLABS) P/E

Dec 16
Some Confidence Is Lacking In PeterLabs Holdings Berhad's (KLSE:PLABS) P/E
YSPSAH
RM 2.09
Y.S.P. Southeast Asia Holding Berhad
7D
-0.5%
1Y
-8.3%
DPHARMA
RM 1.40
Duopharma Biotech Berhad
7D
1.4%
1Y
14.8%
KOTRA
RM 4.08
Kotra Industries Berhad
7D
-1.7%
1Y
-4.9%